Hydrogenology
Hydrogenology editorial study record

Molecular hydrogen decelerates rheumatoid arthritis progression through inhibition of oxidative stress

Meng J, Yu P, Jiang H, Yuan T, Liu N, Tong J, Chen H, Bao N, Zhao J. · American Journal of Translational Research. 2016;8(10):4472–4477.

PreclinicalOther formsPublished 2016
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled collagen-induced-arthritis mouse experiment with complementary human rheumatoid-synovial-cell assays

Research topic

Musculoskeletal and pain research

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Male DBA/1J mice with collagen-induced arthritis and a cultured human rheumatoid-arthritis fibroblast-like synovial cell line.

Sample

Mouse groups were normal control n=10, collagen-induced arthritis plus saline n=10 and collagen-induced arthritis plus hydrogen n=10; the article does not report one consolidated sample count for the repeated cell assays.

Duration

Forty-five days of mouse treatment starting seven days after primary immunization; cell assays covered 24–72 hours.

Intervention

Beginning seven days after primary immunization, mice received hydrogen-saturated saline at 10 mL/kg/day for 45 days. Cultured cells received 0.6 mmol/L H₂-enriched medium together with 0.8 mmol/L hydrogen peroxide for 24 hours, with additional measurements through 72 hours.

Hydrogen form

H₂ dissolved in saline or culture medium — H₂ only, not Brown's gas and not inhalation.

H₂ specification

Hydrogen was dissolved for two hours at 0.4 MPa and the fresh solution was reported above 0.6 mmol/L; cell medium was used at 0.6 mmol/L.

H₂ flow

Not applicable — hydrogen-rich saline and cell medium, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

Saline-treated arthritic mice, non-arthritic controls and matched cell-culture controls.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Arthritis incidence and score, joint histology, synovial-cell proliferation, superoxide dismutase, glutathione, 8-OHdG, MAPK, NF-κB and TGF-β1 signaling.

Reported result

The article reports lower arthritis incidence and scores and less histological damage in hydrogen-treated mice, with changes in oxidative-stress and signaling measures in cultured cells. Exact numerical animal values and uncertainty estimates are sparse in the text and figures.

Results-extraction completeness

The complete open-access article, mouse allocation, preparation and concentration, animal and cell protocols, reported results, funding and conflict statement were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Small mouse groups, mixed animal and cell experiments, sparse numerical reporting and no human treatment arm. The article calls the mouse intervention 'oral hydrogen' in one passage but describes daily intraperitoneal hydrogen-saturated saline in the preparation/administration paragraph; Hydrogenology preserves this unresolved route inconsistency rather than choosing silently. Chinese PLA, National Natural Science Foundation of China and Jiangsu clinical-research grants funded the work; authors disclosed no conflict of interest.

Applies directly to

Collagen-induced arthritis in mice and cultured synovial cells; it does not establish efficacy or dosing in people with rheumatoid arthritis.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 27830032

Publisher access

Open-access PubMed Central article.

Extraction basis

Complete PubMed Central article and PubMed metadata; full-text extraction checked 9 August 2026.

Record revision

2026-08-10